About David Grayzel
Form D filings for Comanche Biopharma in 2024 list David Grayzel as director.
David Grayzel first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Grayzel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Grayzel works with at each company, as listed on that company's latest Form D.
Comanche Biopharma Corp. · Form D, Jan 17, 2024
AT
Ann Taylor
Director
BS
Brendan Bulik-Sullivan
Director
MM
Muzammil Mansuri
Director
AA
Allison August
Executive officer
PA
Paul Antinori
Executive officer
AF
Allyson Felix
Director
TJ
Thomas Johnson
Chief Executive Officer and director
SG
Scott Gottlieb
Director
KP
Ketan Patel
Director
MY
Michael Young
Executive officer